Tisch MS News

9/23/2015 - The staff and researchers at the Tisch MS Research Center would like to wish our Jewish patients, friends and supporters an easy fast on this Yom Kippur.

9/14/2015 - From our office, to your home... the Tisch MS Research Center wishes everyone observing Rosh Hashanah a happy and healthy New Year! L'shanah Tova!

9/4/2015 - The Tisch MSRCNY offices will be closed on Monday, September 7th in observance of Labor Day. The Center will reopen on Tuesday, September 8th. Wishing everyone a safe, happy and healthy holiday weekend!


9/1/15 - Tisch MSRCNY was selected by New York Road Runners (NYRR) as a charity community partner of the 2015 TCS New York City Marathon. We are a dedicated team of runners, including physicians, nurses, patients, and friends of the Tisch Multiple Sclerosis Research Center of New York who have committed themselves to running and raising funds. To learn more and support our runners visit:

MS Patients Continue to Gain Function and Show Improvement

With the International Society for Stem Cell Research’s Annual Meeting as his backdrop, Dr. Saud A. Sadiq delivered more promising results from Tisch MS Research Center of New York’s (Tisch MSRCNY) FDA-approved Phase I stem cell trial. The global event, which serves as the voice of the stem cell community, attracted over 3,500 participants who foster and exchange important dialogue on groundbreaking research in this field.

The Center will close today, Thursday, July 2nd at 5:00pm and will re-open on Monday, July 6th in observance of Independence Day. 

Wishing you all a very safe and happy July 4th holiday! 

Chronogram, a monthly mid-Hudson Valley magazine covering events and ideas that nourish and support the creative life of the region, interviewed IMSMP patients Beth Broun and Liz Maslow Montesano. The interview followed the Tisch MS Research Center’s April announcement at the 2015 American Academy of Neurology Annual Meeting on the preliminary results of its FDA-approved Phase 1 adult stem cell clinical trial to treat patients with multiple sclerosis .

The Tisch MS Research Center will close at 2:00pm today and remain closed through Monday, May 25th. We wish everyone a safe, happy, and healthy holiday weekend.

Interim Results Indicate Positive Efficacy Trends in FDA-Approved Phase I Clinical Stem Cell Trial             For Patients with Multiple Sclerosis

This week eight of Tisch MSRCNY’s researchers arrived in Washington, D.C. to attend the 67th American Academy of Neurology Annual Meeting. Eight of the Center’s Abstracts will be presented at the meeting. Dr. Sadiq was also informed on Monday that the preliminary results from our FDA-approved Phase 1 clinical stem cell trial for patients with MS were selected as a presentation during the Multiple Sclerosis Highlights in the Field session on Wednesday, April 22nd.


Real Time Analytics